Concert Pharmaceutic (CNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 141,636 | 77,202 | 53,043 | 17,770 | 27,665 |
| Marketable Securities | 1,463 | 54,735 | 58,770 | 143,069 | 175,500 |
| Receivables | 218 | 3,177 | 332 | 571 | 783 |
| Other current assets | 15 | 0 | 143 | 16,000 | 0 |
| TOTAL | $150,329 | $142,724 | $116,855 | $180,149 | $205,734 |
| Non-Current Assets | |||||
| PPE Net | 5,242 | 6,363 | 7,753 | 8,919 | 2,165 |
| Other Non-Current Assets | 9,745 | 10,176 | 12,863 | 3,479 | 3,837 |
| TOTAL | $14,987 | $16,539 | $20,616 | $12,398 | $6,002 |
| Total Assets | $165,316 | $159,263 | $137,471 | $192,547 | $211,736 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,606 | 230 | 881 | 1,277 | 658 |
| Accrued Expenses | 12,359 | 9,017 | 8,336 | 5,669 | 4,299 |
| TOTAL | $16,120 | $10,178 | $17,268 | $8,749 | $6,445 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 7,783 | 1,413 | 1,442 |
| Other Non-Current Liabilities | 29,376 | 15,173 | 15,996 | 4,088 | 0 |
| TOTAL | $36,971 | $17,923 | $18,746 | $16,058 | $8,859 |
| Total Liabilities | $53,091 | $28,101 | $36,014 | $24,807 | $15,304 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,953 | 32,174 | 29,637 | 23,529 | 23,233 |
| Common Shares | 34 | 31 | 24 | 23 | 23 |
| Retained earnings | -349,498 | -269,447 | -194,681 | -116,515 | -76,243 |
| Other shareholders' equity | -76 | -58 | -31 | -137 | -407 |
| TOTAL | $112,225 | $131,162 | $101,457 | $167,740 | $196,432 |
| Total Liabilities And Equity | $165,316 | $159,263 | $137,471 | $192,547 | $211,736 |